Actively Recruiting

Age: 18Years +
All Genders
NCT06855368

Biomarkers for Monitoring Dementia Progression

Led by IRCCS San Raffaele Roma · Updated on 2025-03-03

300

Participants Needed

2

Research Sites

136 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The variable course of Alzheimer's disease (AD) and the paucity of adequate cures urges to implement new strategies for its early detection and clinical intervention. Studying the etiopathogenesis and pathophysiological mechanisms of AD is a necessary prerequisite for the development of new biomarkers and innovative therapies. Contrarily to anatomical structures, cortical connectivity networks are already deteriorated in early AD and could be a reliable marker of early cognitive decline. Our aim is to characterize the neurophysiological parameters in mild AD, in patients with mild cognitive impairment and in matched healthy subjects to identify discriminating criteria. Concurrently, the study of AD onset and progression in a mouse model, will allow evaluating the causal effect of inflammation on disease progression and to develop a new class of biomimetic anti-inflammatory nanoparticles formulated to have the intrinsic ability to induce brain's activated microglia to an M2 phenotype.

CONDITIONS

Official Title

Biomarkers for Monitoring Dementia Progression

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of mild Alzheimer's disease or mild cognitive impairment (MCI)
Not Eligible

You will not qualify if you...

  • Major psychosis, genetic, metabolic, or other neurological disorders
  • Acute or chronic medical illness that is not well compensated
  • Any medical or drug-related condition affecting cognitive or mood status
  • History or current alcohol or illicit drug abuse

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

IRCCS San Raffaele

Roma, Italy, 00163

Active, Not Recruiting

2

Azienda Ospedaliero-Universitaria di Sassari

Sassari, Italy, 07100

Actively Recruiting

Loading map...

Research Team

L

Lucia Gatta, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Biomarkers for Monitoring Dementia Progression | DecenTrialz